疑似子痫前期女性中预测小于胎龄儿分娩及不良围产结局
前瞻性多中心观察性研究纳入397例单胎妊娠疑似早产子痫前期女性,评估47种生物标志物和超声参数对小于胎龄儿分娩及不良围产结局的预测性能。在20+0至34+6周组,低胎盘生长因子(PlGF)预测小于胎龄儿(出生体重<第3百分位)的敏感性为93%(95%CI 84-98%),阴性预测值为90%(95%CI 76-97%),优于超声参数。结论认为PlGF测量有助于识别小于胎龄儿高风险者。
要点
- 疑似早产子痫前期女性中,低PlGF预测SGA-3的敏感性93%、NPV 90%。
- 超声参数(EFW或AC<第10百分位)预测SGA-3的敏感性71%、NPV 79%。
- 未发现单一生物标志物优于PlGF,标志物组合仅小幅改善预测性能。
核心结论
- 在疑似早产子痫前期女性中,测量PlGF有助于识别小于胎龄儿分娩高风险者,从而进行适当监测和及时干预。
研究设计与样本
- 前瞻性多中心观察性研究,纳入397例单胎妊娠、孕20+0至36+6周、疑似早产子痫前期女性,入组时确诊子痫前期者排除。
- 测量47种生物标志物和超声参数,按入组孕周分两组进行因子分析和逐步logistic回归。
- 主要结局为分娩出生体重<第3百分位定制曲线的SGA儿(SGA-3),次要结局为出生体重<第10百分位定制曲线的SGA儿及不良围产结局。
主要发现
- 在274例孕20+0至34+6周女性中,96例(35%)分娩SGA-3儿。
- 预测SGA-3,低母体PlGF浓度的敏感性为93%(95%CI 84-98%),NPV为90%(95%CI 76-97%)。
- 超声参数(估计胎儿体重或腹围<第10百分位)预测SGA-3的敏感性为71%(95%CI 58-82%),NPV为79%(95%CI 68-87%)。
- 未发现单一生物标志物预测性能优于PlGF,标志物组合仅小幅改善预测性能。
- 在123例孕35+0至36+6周女性中发现相似结果。
关键数值与推荐
- 低PlGF预测SGA-3:敏感性93%(95%CI 84-98%),NPV 90%(95%CI 76-97%)。
- 超声参数预测SGA-3:敏感性71%(95%CI 58-82%),NPV 79%(95%CI 68-87%)。
临床怎么用
- 作者认为,在疑似早产子痫前期女性中测量PlGF有助于识别小于胎龄儿分娩高风险者,可进行适当监测和及时干预。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the test performance of 47 biomarkers and ultrasound parameters for the prediction of delivery of a small-for-gestational-age (SGA) infant and adverse perinatal outcome in women presenting with suspected pre-eclampsia. METHODS: This was a prospective, multicenter observational study in which 47 biomarkers and ultrasound parameters were measured in 397 women with a singleton pregnancy presenting with suspected preterm pre-eclampsia between 20 + 0 and 36 + 6 weeks' gestation, with the objective of evaluating them as predictors of subsequent delivery of a SGA infant and adverse perinatal outcome. Women with confirmed pre-eclampsia at enrollment were excluded. Factor analysis and stepwise logistic regression were performed in two prespecified groups stratified according to gestational age at enrollment. The primary outcome was delivery of a SGA infant with a birth weight < 3rd customized centile (SGA-3), and secondary outcomes were a SGA infant with a birth weight < 10th customized centile and adverse perinatal outcome. RESULTS: In 274 women presenting at 20 + 0 to 34 + 6 weeks' gestation, 96 (35%) delivered a SGA-3 infant. For prediction of SGA-3, low maternal placental growth factor (PlGF) concentration had a sensitivity of 93% (95% CI, 84-98%) and negative predictive value (NPV) of 90% (95% CI, 76-97%) compared with a sensitivity of 71% (95% CI, 58-82%) and a NPV of 79% (95% CI, 68-87%) for ultrasound parameters (estimated fetal weight or abdominal circumference < 10th centile). No individual biomarker evaluated had a better performance than did PlGF, and marker combinations made only small improvements to the test performance. Similar results were found in 123 women presenting between 35 + 0 and 36 + 6 weeks' gestation. CONCLUSION: In women presenting with suspected preterm pre-eclampsia, measurement of PlGF offers a useful adjunct for identifying those at high risk of delivering a SGA infant, allowing appropriate surveillance and timely intervention. © 2017 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Griffin M, Seed PT, Duckworth S, et al. Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia. Ultrasound Obstet Gynecol. 2018. PMID: 28401605. doi:10.1002/uog.17490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。